Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2012

Open Access 01-12-2012 | Research article

Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis

Authors: Cheng Liu, Gaoqiang Wang, Gaofeng Chen, Yongping Mu, Lijun Zhang, Xudong Hu, Mingyu Sun, Chenghai Liu, Ping Liu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2012

Login to get access

Abstract

Background

Previously, Huangqi decoction (HQD) has been found to have a potential therapeutic effect on DMN-induced liver cirrhosis. Here, the mechanisms of HQD action against liver fibrosis were investigated in relation to hepatocyte apoptosis and hepatic inflammation regulation.

Methods

Liver fibrosis was induced by DMN administration for 2 or 4 weeks. Hepatocyte apoptosis and of Kupffer cells (KC) and hepatic stellate cells (HSC) interaction were investigated using confocal microscopy. The principle cytokines, fibrogenic proteins and apoptotic factors were investigated using western blot analysis.

Results

Compared with the DMN-water group, HQD showed decreased hepatocyte apoptosis and reduced expression of apoptotic effectors, cleaved-caspase-3, and fibrotic factors, such as smooth muscle α-actin (α-SMA), transforming growth factor beta-1 (TGF-β1). However, the KC marker CD68 increased significantly in DMN-HQD liver. Confocal microscopy demonstrated widespread adhesion of KCs to HSCs in DMN-water and DMN-HQD rats liver.

Conclusions

HQD exhibited positive protective effects against liver fibrosis; its mechanism of action was associated with protection from hepatocyte apoptosis and the promotion of CD68 expression in the devolopment of liver fibrosis to cirrhosis development.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hernandez-Gea V, Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011, 28: 425-456.CrossRef Hernandez-Gea V, Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011, 28: 425-456.CrossRef
2.
3.
go back to reference Friedman SL, Rockey DC, Bissell DM: Hepatic fibrosis 2006: report of the third AASLD single topic conference. Hepatology. 2007, 45: 242-249. 10.1002/hep.21459.CrossRefPubMed Friedman SL, Rockey DC, Bissell DM: Hepatic fibrosis 2006: report of the third AASLD single topic conference. Hepatology. 2007, 45: 242-249. 10.1002/hep.21459.CrossRefPubMed
4.
go back to reference Greets A: Sho-Saiko-To: The Right Blend of Traditional Oriental Medicine and Liver Cell Biology. Hepatology. 1999, 29: 282-284. 10.1002/hep.510290129.CrossRef Greets A: Sho-Saiko-To: The Right Blend of Traditional Oriental Medicine and Liver Cell Biology. Hepatology. 1999, 29: 282-284. 10.1002/hep.510290129.CrossRef
5.
go back to reference Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J: Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006, 130: 1564-1572. 10.1053/j.gastro.2006.01.042.CrossRefPubMed Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J: Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006, 130: 1564-1572. 10.1053/j.gastro.2006.01.042.CrossRefPubMed
6.
go back to reference Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, Casini A: Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology. 2002, 122: 1924-1940. 10.1053/gast.2002.33666.CrossRefPubMed Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, Casini A: Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology. 2002, 122: 1924-1940. 10.1053/gast.2002.33666.CrossRefPubMed
7.
go back to reference Minics SD, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA, Schwabe RF: Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology. 2007, 132: 1937-1946. 10.1053/j.gastro.2007.02.033.CrossRef Minics SD, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA, Schwabe RF: Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology. 2007, 132: 1937-1946. 10.1053/j.gastro.2007.02.033.CrossRef
8.
go back to reference Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005, 115: 56-65.CrossRefPubMedPubMedCentral Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005, 115: 56-65.CrossRefPubMedPubMedCentral
10.
go back to reference Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, Peng J, Hu Y, Liu C, Liu P: Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest. 2010, 90: 1805-1816. 10.1038/labinvest.2010.123.CrossRefPubMed Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, Peng J, Hu Y, Liu C, Liu P: Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest. 2010, 90: 1805-1816. 10.1038/labinvest.2010.123.CrossRefPubMed
11.
go back to reference Wang QL, Yuan JL, Tao YY, Zhang Y, Liu P, Liu CH: Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition. J Ethnopharmacol. 2010, 27: 631-640.CrossRef Wang QL, Yuan JL, Tao YY, Zhang Y, Liu P, Liu CH: Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition. J Ethnopharmacol. 2010, 27: 631-640.CrossRef
12.
go back to reference Liu C, Hu Y, Xu L, Liu C, Liu P: Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med. 2009, 29: 12-CrossRef Liu C, Hu Y, Xu L, Liu C, Liu P: Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med. 2009, 29: 12-CrossRef
13.
go back to reference Wang L, Liu P, Mu Y, Long A, Du G: Study on TCM Recipe and Syndrome of dimethylnitrosamine-induced hepatic fibrosis in rats. J Tradi Chin Med. 2006, 47: 929-932. Wang L, Liu P, Mu Y, Long A, Du G: Study on TCM Recipe and Syndrome of dimethylnitrosamine-induced hepatic fibrosis in rats. J Tradi Chin Med. 2006, 47: 929-932.
14.
go back to reference Liu C, Sun MY, Wang L, Wang G, Chen G, Liu C, Liu P: Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats. Chin Med. 2008, 3: 1-10.1186/1749-8546-3-1.CrossRefPubMedPubMedCentral Liu C, Sun MY, Wang L, Wang G, Chen G, Liu C, Liu P: Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats. Chin Med. 2008, 3: 1-10.1186/1749-8546-3-1.CrossRefPubMedPubMedCentral
15.
go back to reference Ala-Kokko L, Pihlajaniemi T, Myers JC, Kivirikko KI, Savolainen ER: Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J. 1987, 244: 75-79.CrossRefPubMedPubMedCentral Ala-Kokko L, Pihlajaniemi T, Myers JC, Kivirikko KI, Savolainen ER: Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J. 1987, 244: 75-79.CrossRefPubMedPubMedCentral
16.
go back to reference Scheuer PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991, 13: 372-374. 10.1016/0168-8278(91)90084-O.CrossRefPubMed Scheuer PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991, 13: 372-374. 10.1016/0168-8278(91)90084-O.CrossRefPubMed
17.
go back to reference Jamall IS, Finelli VN, Que Hee SS: A simple method to determine nanogram levels of 4-hydroyproline in biological tissues. Anal Biochem. 1981, 112: 70-75. 10.1016/0003-2697(81)90261-X.CrossRefPubMed Jamall IS, Finelli VN, Que Hee SS: A simple method to determine nanogram levels of 4-hydroyproline in biological tissues. Anal Biochem. 1981, 112: 70-75. 10.1016/0003-2697(81)90261-X.CrossRefPubMed
18.
go back to reference Prichard DJ, Butler WH: Apoptosis-a mechanism of cell death in DMN induced hepatotoxicity. J Pathol. 1989, 158: 253-260. 10.1002/path.1711580314.CrossRef Prichard DJ, Butler WH: Apoptosis-a mechanism of cell death in DMN induced hepatotoxicity. J Pathol. 1989, 158: 253-260. 10.1002/path.1711580314.CrossRef
19.
go back to reference Horn TL, Bhattacharjee A, Schook LB, Rutherford MS: Altered hepatic mRNA expression of apoptotic genes during dimethylnitrosamine exposure. Toxicol Sci. 2000, 57: 240-249. 10.1093/toxsci/57.2.240.CrossRefPubMed Horn TL, Bhattacharjee A, Schook LB, Rutherford MS: Altered hepatic mRNA expression of apoptotic genes during dimethylnitrosamine exposure. Toxicol Sci. 2000, 57: 240-249. 10.1093/toxsci/57.2.240.CrossRefPubMed
20.
go back to reference Buechler C, Ritter M, Orsó E, Langmann T, Kluchen J, Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti-inflammatory stimuli. J Leukoc Biol. 2000, 67: 97-103.PubMed Buechler C, Ritter M, Orsó E, Langmann T, Kluchen J, Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti-inflammatory stimuli. J Leukoc Biol. 2000, 67: 97-103.PubMed
21.
go back to reference Nakamuta M, Ohta S, Tada S, Tsuruta S, Sugimoto R, Kotoh K, Kato M, Nakashima Y, Enjoji M, Nawata H: Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med. 2001, 8: 553-560.PubMed Nakamuta M, Ohta S, Tada S, Tsuruta S, Sugimoto R, Kotoh K, Kato M, Nakashima Y, Enjoji M, Nawata H: Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med. 2001, 8: 553-560.PubMed
22.
go back to reference Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F: A morphological study of the early stage of hepatic fibrosis induced by low dose of DMN in the rats. J Hepatol. 1987, 5: 174-181. 10.1016/S0168-8278(87)80570-6.CrossRefPubMed Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F: A morphological study of the early stage of hepatic fibrosis induced by low dose of DMN in the rats. J Hepatol. 1987, 5: 174-181. 10.1016/S0168-8278(87)80570-6.CrossRefPubMed
23.
go back to reference Asano Y, Iimuro Y, Son G, Hirano T, Fujimoto J: Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver. Hepatol Res. 2007, 37: 1080-1094. 10.1111/j.1872-034X.2007.00206.x.CrossRefPubMed Asano Y, Iimuro Y, Son G, Hirano T, Fujimoto J: Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver. Hepatol Res. 2007, 37: 1080-1094. 10.1111/j.1872-034X.2007.00206.x.CrossRefPubMed
24.
go back to reference Xia JL, Dai C, Michalopoulos GK, Liu Y: Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol. 2006, 168: 1500-1512. 10.2353/ajpath.2006.050747.CrossRefPubMedPubMedCentral Xia JL, Dai C, Michalopoulos GK, Liu Y: Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol. 2006, 168: 1500-1512. 10.2353/ajpath.2006.050747.CrossRefPubMedPubMedCentral
25.
go back to reference Kiyama S, Yamada T, Iwata H, Sekino T, Matsuo H, Yoshida N, Miyahara T, Umeda Y, Matsuno Y, Kimura M, Matsumoto K, Nakamura T, Takemura H: Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. J Gastroenterol Hepatol. 2008, 23: 471-476. 10.1111/j.1440-1746.2007.05111.x.CrossRef Kiyama S, Yamada T, Iwata H, Sekino T, Matsuo H, Yoshida N, Miyahara T, Umeda Y, Matsuno Y, Kimura M, Matsumoto K, Nakamura T, Takemura H: Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. J Gastroenterol Hepatol. 2008, 23: 471-476. 10.1111/j.1440-1746.2007.05111.x.CrossRef
26.
go back to reference Umeda Y, Marui T, Matsuno Y, Shirahashi K, Iwata H, Takagi H, Matsumoto K, Nakamura T, Kosugi A, Mori Y, Takemura H: Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice. Lab Invest. 2004, 84: 836-844. 10.1038/labinvest.3700098.CrossRefPubMed Umeda Y, Marui T, Matsuno Y, Shirahashi K, Iwata H, Takagi H, Matsumoto K, Nakamura T, Kosugi A, Mori Y, Takemura H: Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice. Lab Invest. 2004, 84: 836-844. 10.1038/labinvest.3700098.CrossRefPubMed
28.
go back to reference Reeves HL, Burt AD, Wood S, Day CP: Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol. 1996, 25: 677-683. 10.1016/S0168-8278(96)80238-8.CrossRefPubMed Reeves HL, Burt AD, Wood S, Day CP: Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol. 1996, 25: 677-683. 10.1016/S0168-8278(96)80238-8.CrossRefPubMed
29.
go back to reference Stenback F, Ala-Kokko L, Ryhanen L: Morphological, immunohistochemical and ultrastructural changes in dimethylnitrosamine-induced liver injury. Effect of malotilate. Histol Histopathol. 1989, 4: 95-104.PubMed Stenback F, Ala-Kokko L, Ryhanen L: Morphological, immunohistochemical and ultrastructural changes in dimethylnitrosamine-induced liver injury. Effect of malotilate. Histol Histopathol. 1989, 4: 95-104.PubMed
30.
go back to reference Topoll HH, Zwadlo G, Lange DE, Sorg C: Phenotypic dynamics of macrophage subpopulations during experimental gingivitis. J Periodontal Res. 1989, 24: 106-112. 10.1111/j.1600-0765.1989.tb00864.x.CrossRefPubMed Topoll HH, Zwadlo G, Lange DE, Sorg C: Phenotypic dynamics of macrophage subpopulations during experimental gingivitis. J Periodontal Res. 1989, 24: 106-112. 10.1111/j.1600-0765.1989.tb00864.x.CrossRefPubMed
31.
go back to reference Ide M, Kuwamura M, Kotani T, Sawamoto O, Yamate J: Effects of gadolinium chloride (GdCl3) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions. J Comp Pathol. 2005, 133: 92-102. 10.1016/j.jcpa.2005.01.011.CrossRefPubMed Ide M, Kuwamura M, Kotani T, Sawamoto O, Yamate J: Effects of gadolinium chloride (GdCl3) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions. J Comp Pathol. 2005, 133: 92-102. 10.1016/j.jcpa.2005.01.011.CrossRefPubMed
32.
go back to reference Friedman SL, Arthur MJ: Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest. 1989, 84: 1780-1785. 10.1172/JCI114362.CrossRefPubMedPubMedCentral Friedman SL, Arthur MJ: Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest. 1989, 84: 1780-1785. 10.1172/JCI114362.CrossRefPubMedPubMedCentral
33.
go back to reference Natalia N: Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells. Hepatology. 2006, 44: 1487-1501. 10.1002/hep.21427.CrossRef Natalia N: Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells. Hepatology. 2006, 44: 1487-1501. 10.1002/hep.21427.CrossRef
Metadata
Title
Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis
Authors
Cheng Liu
Gaoqiang Wang
Gaofeng Chen
Yongping Mu
Lijun Zhang
Xudong Hu
Mingyu Sun
Chenghai Liu
Ping Liu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2012
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-12-51

Other articles of this Issue 1/2012

BMC Complementary Medicine and Therapies 1/2012 Go to the issue